Biotech
Pharma
CRO/CMO/CDMO
Medtech
Bioinformatics
Advisor
Peter Kurz
Over a career spanning 40 years, Peter has emerged as a leading financial commentator and analyst of the Taiwan markets and industries, earning him the moniker of Mr. Taiwan. He currently serves as Chief Strategy Officer at Quantum International Corporation (QIC) where he advises companies on accessing international capital markets.
At QIC, Peter and his team members have counted most of the major companies in this sector as among their clientele, including PharmaEssentia, Oneness, and Foresee. They have, moreover, been advising numerous early-stage and pre-IPO biotech companies on fundraising strategies.
Finally, Peter devised the motto "HEADs Up" to underscore the four industries that QIC views as those that will lead Taiwan's economic growth going forward – Health Tech, Energy Tech, Automotive Tech, and Data-based businesses. QIC has since created several conferences and events around this theme.
Advisor
KJ Wang
KJ brings extensive hands-on experience in biopharma, equity research, and investment banking to QIC, focusing on value creation in the healthcare industry. During his 11-year tenure at QIC, KJ facilitated more than 30 corporations in raising their profile as investment opportunities, allowing investors to evaluate and make informed decisions. Key accounts include PharmaEssentia, Oneness Biotech, Foresee Pharmaceuticals, Polaris Pharmaceuticals, Adimmune, Senhwa Biosciences, Coland Holdings, Chlitina, and CHC Group.
KJ and his team help companies identify suitable investors. They introduce companies to those investors on global non-deal roadshows and at conferences. He and the team also assist in fundraising and mergers and acquisitions. When necessary and appropriate, they help place stock, improve liquidity, and translate clients' ESG efforts to improved ratings.
Advisor
Jerry Huang
Jerry is a member of QIC's healthcare team, contributing to value-creation projects within the healthcare industry. His responsibilities include assisting clients in identifying suitable investors, conducting global non-deal roadshows, building financial models and investor presentations. Key accounts include PharmaEssentia, Oneness Biotech, Foresee Pharmaceuticals, Zhen Ding, WIN Semi, and Gamania. Additionally, Jerry actively monitors the Taiwan healthcare sector, specifically identifying companies with significant potential for growth or investment.
Advisor
Peter Kurz
Over a career spanning 40 years, Peter has emerged as a leading financial commentator and analyst of the Taiwan markets and industries, earning him the moniker of Mr. Taiwan. He currently serves as Chief Strategy Officer at Quantum International Corporation (QIC) where he advises companies on accessing international capital markets.
At QIC, Peter and his team members have counted most of the major companies in this sector as among their clientele, including PharmaEssentia, Oneness, and Foresee. They have, moreover, been advising numerous early-stage and pre-IPO biotech companies on fundraising strategies.
Finally, Peter devised the motto "HEADs Up" to underscore the four industries that QIC views as those that will lead Taiwan's economic growth going forward – Health Tech, Energy Tech, Automotive Tech, and Data-based businesses. QIC has since created several conferences and events around this theme.
Advisor
KJ Wang
KJ brings extensive hands-on experience in biopharma, equity research, and investment banking to QIC, focusing on value creation in the healthcare industry. During his 11-year tenure at QIC, KJ facilitated more than 30 corporations in raising their profile as investment opportunities, allowing investors to evaluate and make informed decisions. Key accounts include PharmaEssentia, Oneness Biotech, Foresee Pharmaceuticals, Polaris Pharmaceuticals, Adimmune, Senhwa Biosciences, Coland Holdings, Chlitina, and CHC Group.
KJ and his team help companies identify suitable investors. They introduce companies to those investors on global non-deal roadshows and at conferences. He and the team also assist in fundraising and mergers and acquisitions. When necessary and appropriate, they help place stock, improve liquidity, and translate clients' ESG efforts to improved ratings.
Advisor
Jerry Huang
Jerry is a member of QIC's healthcare team, contributing to value-creation projects within the healthcare industry. His responsibilities include assisting clients in identifying suitable investors, conducting global non-deal roadshows, building financial models and investor presentations. Key accounts include PharmaEssentia, Oneness Biotech, Foresee Pharmaceuticals, Zhen Ding, WIN Semi, and Gamania. Additionally, Jerry actively monitors the Taiwan healthcare sector, specifically identifying companies with significant potential for growth or investment.
Clients
聯絡我們
有任何疑問或合作需求，歡迎隨時與我們聯絡。